Incon Co., Ltd. Appoints Stephen C. Glover to its Board of Directors
December 03, 2018 at 07:08 am
Share
Variant Pharmaceuticals Inc. (Variant) announced that it has secured $10 Million in financing from Incon, in exchange for equity ownership. Funding will be used to advance clinical and non-clinical development of VAR 200 (2HPßCD), including production of clinical supplies, execution of the Phase 2a trial in patients with FSGS, and support for expanded access and subcutaneous delivery initiatives. Additionally, Incon has been awarded a seat on Variant's Board of Directors, and Stephen C. Glover, Variant's Co-founder, Chief Executive Officer, and Chairman will join Incon's Board of Directors.
INCON Co., Ltd., formerly Win4Net Co., Ltd. is a Korea-based company specialized in the development and manufacture of digital video recorders (DVRs) used for security area. The Companyâs products consist of standalone DVRs, personal computer (PC)-based DVRs, analog cameras, color box cameras, indoor dome cameras, outdoor micro dome cameras, outdoor dome cameras and others. Its Internet protocol (IP) products include network video recorders (NVRs), video servers, hybrid DVRs, IP cameras and related software. It also provides storages. It distributes its products under the brand names of Netsafe, Trium, Poswatch, Clevo, Netsafe, Wintera and others. The Company distributes its products within domestic market and to overseas markets.
INCON CO.,LTD. 
